Evening all, in light of the recent 22/3 government advice regarding ‘shielding’ for vulnerable groups, the message appears to be people falling into this group include thise with cancers of the blood or bone marrow such as leukaemia, lymphoma or myeloma who are at any stage of treatment. Does my ET condition, for which I’m taking Hydroxycarbamide include me in this group? I hope to speak to my haematologist on my next appt, but it’s not for a couple of weeks and don’t know if it’s likly to go ahead at this stage as appointments may be changed by then. I’m social distancing, but am walking the dog and getting the odd bit of shopping. so wanted some reassurance over what to expect and what I should be doing. Any advice would be apriciated.